Disclosure 0001493152-26-037480-1

SEC FORM 4

$527,842.80

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 30,868 shares at $17.10 per share.

Reporting Person Furney Natalie Anne Marie · Officer Title Global General Counsel · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037480 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TAKEDA PHARMACEUTICAL CO LTD (TAK)." Disclosed 2026-08-12. https://desqlong.com/cards/0001493152-26-037480-1 (retrieved 2026-09-26).